Activation of early components of complement targets myelin and oligodendrocytes in the aged rhesus monkey brain

被引:25
作者
Duce, JA
Hollander, W
Jaffe, R
Abraham, CR
机构
[1] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA
[2] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA
关键词
aging; myelin; oligodendrocyte; complement activation;
D O I
10.1016/j.neurobiolaging.2005.03.027
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
The disruption and loss of myelin in the white matter are some of the major changes that occur in the brain with age. In vitro studies suggest a role of the complement system in the catabolic breakdown of myelin membranes. This study presents findings on activation of the early components of complement cascade in the brains of both young and aged rhesus monkeys with evidence of increased complement activation in aged animals. Complement containing oligodendrocytes (CAOs) containing C3d and C4d complement activation products bound to oligodendrocytes and myelinated fibers were found in the brain of normal Young and old animals. The CAOs, which also contained activated microglia, were distributed throughout the whole brain and in significantly greater numbers in the aged monkeys. These findings, together with the demonstration of covalent binding of the C3 fragments to Myelin, Suggest the initiation of the complement cascade by myelin and oligodendrocytes, which are known classical complement activators. Activation of terminal complement components was not demonstrable in the CAOs. Taken together the findings support the concept that activation of early components of complement in the brain may be a normal biological process that involves the metabolism of myelin and oligodendrocytes and up-regulates with age. (C) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:633 / 644
页数:12
相关论文
共 67 条
[61]   Macrophage phagocytosis of myelin in vitro determined by flow cytometry: Phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide [J].
vanderLaan, LJW ;
Ruuls, SR ;
Weber, KS ;
Lodder, IJ ;
Dopp, EA ;
Dijkstra, CD .
JOURNAL OF NEUROIMMUNOLOGY, 1996, 70 (02) :145-152
[62]   COMPLEMENT ACTIVATION BY ISOLATED MYELIN - ACTIVATION OF THE CLASSICAL PATHWAY IN THE ABSENCE OF MYELIN-SPECIFIC ANTIBODIES [J].
VANGURI, P ;
KOSKI, CL ;
SILVERMAN, B ;
SHIN, ML .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (10) :3290-3294
[63]  
VANGURI P, 1988, J BIOL CHEM, V263, P7228
[64]   Advances in immunology: Complement (First of two parts). [J].
Walport, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14) :1058-1066
[65]   ACTIVATION OF ADULT HUMAN-DERIVED MICROGLIA BY MYELIN PHAGOCYTOSIS IN-VITRO [J].
WILLIAMS, K ;
ULVESTAD, E ;
WAAGE, A ;
ANTEL, JP ;
MCLAURIN, J .
JOURNAL OF NEUROSCIENCE RESEARCH, 1994, 38 (04) :433-443
[66]   COMPLEMENT-ACTIVATED OLIGODENDROGLIA - A NEW PATHOGENIC ENTITY IDENTIFIED BY IMMUNOSTAINING WITH ANTIBODIES TO HUMAN-COMPLEMENT PROTEINS C3D AND C4D [J].
YAMADA, T ;
AKIYAMA, H ;
MCGEER, PL .
NEUROSCIENCE LETTERS, 1990, 112 (2-3) :161-166
[67]  
ZAJICEK J, 1995, LAB INVEST, V73, P128